Hypertrophy: Enlargement of an organ or part due to increase in the size of the
constituent cells.
Hypochromia: A decrease in color of the erythrocytes, hence a decrease in their
hemoglobin content.
Hypoplasia: A decrease in cell formation.
Hypotonic: Less than isotonic concentration.
Idiopathic: Disease of unknown cause.
Inclusion:
Usually lifeless, an
accumulation of
fats, proteins, crystals pigments or
secretory granules within a cell cytoplasm.
Inhibitor: A substance, directed against a coagulation factor or factors, which interferes
with the coagulation process.
Intravascular: Occurring within the blood vessels.
Intrinsic: Situated within the particular part.
In Vitro: Within a test tube (glass, etc.).
In Vivo: Within the living organism, as in life.
Isotonic: Solutions with the same osmotic pressure.
Jaundice:
Yellow mass of
the skin and eyes due to
the presence of
blood pigments in
the blood; follows excessive destruction of the blood, obstruction of the bile passage,
diffuse liver disease, certain infections, toxic chemical agents and drugs.
Juvenile Cell: In the Schilling classification, the cell between the myelocyte and band
forms; also metamyelocyte.
Karyolysis: Apparent destruction of the nucleus of a cell.
Karyorrhexis: Fragmentation of the nucleus; a degenerative process usually followed
by karyolysis.
L.E. Cell: A large segmented neutrophil or eosinophil that contains ingested autolyzed
nuclear fragments in its cytoplasm.
Leukemia: An ultimately fatal disease of the blood-forming organs characterized by
increased numbers of leukocytes and associated anemia.
MD0853
A-6